Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Antigen processing and presentation | R-HSA-1236975 | map04612 | cefadroxil | 3950 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | cefadroxil | 3950 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | cefadroxil | 3950 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefadroxil | 3950 | drug-path |
Asthma | R-HSA-444620 | map05310 | cefadroxil | 3950 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | cefadroxil | 3950 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | cefadroxil | 3950 | drug-path |
Circadian rhythm - mammal | R-HSA-400253 | 0 | cefadroxil | 3950 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | cefadroxil | 3950 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | cefadroxil | 3950 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | cefadroxil | 3950 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | prednicarbate | 6714002 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | prednicarbate | 6714002 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | prednicarbate | 6714002 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | prednicarbate | 6714002 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | prednicarbate | 6714002 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | prednicarbate | 6714002 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | prednicarbate | 6714002 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | prednicarbate | 6714002 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | prednicarbate | 6714002 | drug-path |